Angiotensin-converting-enzyme inhibitor administration must be monitored for serum amylase and lipase in order to prevent an acute pancreatitis: A case report

Angiology

Volumn 52, Issue 9, 2001, Pages 645-647

  Borgia, Maria ^a   Celestini, Andrea ^a   Caravella, Patrizia ^a   Catalano, Carlo ^a,b  

^a Department of Clinical Science ^*  (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMYLASE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; AGED; ALCOHOL ABUSE; AMYLASE BLOOD LEVEL; ARTICLE; CASE REPORT; CHOLESTASIS; DRUG INDUCED DISEASE; ENZYME ANALYSIS; ENZYME INHIBITOR INTERACTION; HUMAN; HYPERCALCEMIA; HYPERTENSION; MALE; NEUTROPHIL; SUSPENSION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ACUTE DISEASE; AGED; AMYLASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; HUMANS; HYPERTENSION; LIPASE; MALE; PANCREATITIS;

EID: 0034821228     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970105200910     Document Type: Article

References (6)

1. ACE-inhibitors and pancreatitis
2. Quinapril and pancreatitis
3. Enalapril-associated acute pancreatitis recurrence after rechallenge
4. Enalapril/hydrochlorothiazide-induced angioneurotic edema and acute pancreatitis
5. Angiotensin-converting-enzyme inhibitor-induced pancreatitis
6. Drug-induced pancreatitis